TY - JOUR
T1 - Risk factors for malignant progression of intraductal papillary mucinous neoplasms
AU - Moris, Maria
AU - Raimondo, Massimo
AU - Woodward, Timothy A.
AU - Skinner, Verna
AU - Arcidiacono, Paolo G.
AU - Petrone, Maria C.
AU - De Angelis, Claudio
AU - Manfrè, Selene
AU - Fusaroli, Pietro
AU - Wallace, Michael B.
N1 - Funding Information:
MBW receives grant funding from Olympus, Boston Scientific, and Cosmo Pharmaceuticals. None of the other authors have conflicts of interest to disclose.
Funding Information:
This project was funded by The Joyce E. Baker Foundation for research at Mayo Clinic in Florida.
Publisher Copyright:
© 2015 Editrice Gastroenterologica Italiana S.r.l..
PY - 2015/6/1
Y1 - 2015/6/1
N2 - Background: Intraductal papillary mucinous neoplasms of the pancreas are increasingly diagnosed. Due to their malignant potential, greater understanding of their nature is required. Aims: Define risk factors for malignancy in intraductal papillary mucinous neoplasms. Methods: An international, multicentre study was performed in Europe and the United States. Clinical databases were reviewed for patients with intraductal papillary mucinous neoplasms diagnosis. Results: Of 1126 patients, 84 were diagnosed with invasive carcinoma/high-grade dysplasia and were compared to the rest of the cohort. Multivariate logistic analysis showed a statistically significant association between cancer/high-grade dysplasia and the variables smoking history (OR 1.9, 95% CI [1.1-3.1]), body mass index (OR 1.1, 95% CI [1-1.1]), symptoms (OR 3.4, 95% CI [1.9-6]), jaundice (OR 0.1, 95% CI [0-0.3]), and steatorrhea (OR 0.3, 95% CI [0.1-0.8]). Univariate analysis showed no association between malignancy and the cyst number/location (. p=. 0.3 and p=. 0.5, respectively) although a strong association was shown for cyst size (. p<. 0.001). The presence and size of nodules (. p<. 0.01) and main duct involvement (. p<. 0.001) were also strongly related with malignancy. Conclusion: The presence of jaundice and steatorrhea, smoking, high body mass index, and imaging features such as cyst size, main duct involvement, and the presence and size of mural nodules are associated with high-grade neoplasia in intraductal papillary mucinous neoplasms.
AB - Background: Intraductal papillary mucinous neoplasms of the pancreas are increasingly diagnosed. Due to their malignant potential, greater understanding of their nature is required. Aims: Define risk factors for malignancy in intraductal papillary mucinous neoplasms. Methods: An international, multicentre study was performed in Europe and the United States. Clinical databases were reviewed for patients with intraductal papillary mucinous neoplasms diagnosis. Results: Of 1126 patients, 84 were diagnosed with invasive carcinoma/high-grade dysplasia and were compared to the rest of the cohort. Multivariate logistic analysis showed a statistically significant association between cancer/high-grade dysplasia and the variables smoking history (OR 1.9, 95% CI [1.1-3.1]), body mass index (OR 1.1, 95% CI [1-1.1]), symptoms (OR 3.4, 95% CI [1.9-6]), jaundice (OR 0.1, 95% CI [0-0.3]), and steatorrhea (OR 0.3, 95% CI [0.1-0.8]). Univariate analysis showed no association between malignancy and the cyst number/location (. p=. 0.3 and p=. 0.5, respectively) although a strong association was shown for cyst size (. p<. 0.001). The presence and size of nodules (. p<. 0.01) and main duct involvement (. p<. 0.001) were also strongly related with malignancy. Conclusion: The presence of jaundice and steatorrhea, smoking, high body mass index, and imaging features such as cyst size, main duct involvement, and the presence and size of mural nodules are associated with high-grade neoplasia in intraductal papillary mucinous neoplasms.
KW - Pancreatic adenocarcinoma
KW - Pancreatic cystic neoplasm
UR - http://www.scopus.com/inward/record.url?scp=84930179541&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930179541&partnerID=8YFLogxK
U2 - 10.1016/j.dld.2015.03.007
DO - 10.1016/j.dld.2015.03.007
M3 - Article
C2 - 25869552
AN - SCOPUS:84930179541
SN - 1590-8658
VL - 47
SP - 495
EP - 501
JO - Digestive and Liver Disease
JF - Digestive and Liver Disease
IS - 6
ER -